Infectious Diseases Data Observatory (IDDO)
banner
iddonews.bsky.social
Infectious Diseases Data Observatory (IDDO)
@iddonews.bsky.social
Pioneers in generating new research evidence from existing data since 2009 - putting equity for global researchers at the forefront.
🚨 We’re hiring! 🚨
We are looking for a Head of #DataEngineering & #Informatics to play a leading role in our ongoing development & lead our data strategy
📍 Oxford, UK 📅 Apply by Jan 12 🔗 www.iddo.org/about-us/jobs
#NTDs #EmergingInfections #malaria #GlobalHealth
@tropicalmedicine.ox.ac.uk @ox.ac.uk
December 9, 2025 at 4:40 PM
🎥 Watch Dawit Getachew Assefa (Dilla University, Ethiopia) talk about how his year with IDDO - through the @who.int #TDRnews Postgraduate Research Fellowship - how it has positively impacted his career, his institution and his students.
December 9, 2025 at 8:01 AM
Are you attending @rstmh.bsky.social Research in Progress meeting tomorrow in #London ?
Watch out for IDDO researchers Dr Aninda Moitry & Dr Nathalie Beloum who will be presenting their work on #malaria
December 8, 2025 at 3:02 PM
Are you researching #InfectiousDiseases #EmergingInfections #malaria #AMR or #NTDs? The datasets we host harmonise tens of thousands of individual patient data, enabling researchers to answer new questions from existing data. Learn more www.iddo.org/data-sharing #BeatNTDs
December 8, 2025 at 7:45 AM
📢New paper alert!
Rapid, low-cost tests repurposed by researchers can now detect deadly contaminants in medicinal syrups that could help prevent the tragic child deaths seen worldwide
@oxfordbiochemistry.bsky.social @kavlioxford.bsky.social @bevingan.bsky.social
👉
Rapid, low-cost tests to help prevent child deaths from contaminated medicinal syrups | Infectious Diseases Data Observatory
Professor Paul Newton, who heads the Medicine Quality Research group, is the project lead for large collaboration that has demonstrated that simple, rapid, and inexpensive tests can detect deadly…
www.iddo.org
December 5, 2025 at 2:14 PM
Calling all researchers working in #InfectiousDiseases #EmergingInfections or #NTDs? You can use our free tools, resources to support your work www.iddo.org/tools-and-re...
#BeatNTDs
December 5, 2025 at 8:15 AM
🎉 Big news! Our website just got a makeover - cleaner navigation, fresh layout and a brand-new blog section.
Take a look and tell us what you think! 👀✨
👉 www.iddo.org
December 4, 2025 at 9:00 AM
📢 📢 New paper alert!

Read new paper on developing a #VL data reuse platform and research agenda and how they can play a vital role furthering knowledge and optimal treatments for #VisceralLeishmaniasis
#BeatNTDs
www.iddo.org/news/data-pl...
@prabindahal.bsky.social
December 4, 2025 at 8:01 AM
🎥 Watch Dawit Getachew Assefa, of Dilla University, Ethiopia, share his experience about his 12-months with IDDO!
@who.int #TDRnews
👉https://www.iddo.org/news/dawit-getachew-assefas-fellowship-reflections
December 3, 2025 at 9:30 AM
📢 New Blog Alert!
Read new post by Dr Nathalie Beloum, one of our new @who.int #TDRnews Fellows. Here she shares her journey through the application process, her first impressions, the projects she’ll be working on and her hopes for the placement
👉 Read her story www.iddo.org/news/introdu...
December 2, 2025 at 3:15 PM
✨ Exciting news! ✨
Our website just got a fresh new makeover! 🙌
We’ve reorganised things to make everything easier to find, smoother to navigate & more enjoyable to explore. Plus we’ve launched an new blog section!
Take a look around & let us know what you think
👉 www.iddo.org
December 2, 2025 at 10:00 AM
#ScienceReadForSunday: Global genomic and antimicrobial resistance profiling of Neisseria gonorrhoeae: Insights from whole genome sequencing and minimum inhibitory concentration analysis
journals.plos.org/plosntds/art...
Global genomic and antimicrobial resistance profiling of Neisseria gonorrhoeae: Insights from whole genome sequencing and minimum inhibitory concentration analysis
Author summary Neisseria gonorrhoeae, the bacterium responsible for the sexually transmitted infection gonorrhea, has become increasingly resistant to many antibiotics once relied upon for treatment.…
journals.plos.org
November 30, 2025 at 10:15 AM
Use the free to download case report form for #Chagas disease to collect data in a standardised format to accelerate research and #BeatNTDs
#WorldChagasDay
www.iddo.org/chagas/resea...
@dndi.org
November 28, 2025 at 7:30 AM
Track news reports of #SubstandardMedicines and #FalsifiedMedicine in your country. View our Medicine Quality Monitoring Globe, which filters by key words, time-periods, locations, and language. #medswecantrust
@tropicalmedicine.ox.ac.uk @moru-mip.bsky.social
www.iddo.org/medicine-qua...
Medicine Quality Monitoring Globe | Infectious Diseases Data Observatory
Substandard and falsified medical products, including medicines, vaccines, diagnostic tests and devices are critical global public health issues. Discover a new interactive, online tool mapping…
www.iddo.org
November 26, 2025 at 8:01 AM
Watch our #DataSharing animation below to see how we accelerate better treatments for people with neglected poverty-related diseases by generating research evidence through data re-use #NTDs www.youtube.com/watch?v=4o0z...
IDDO Data Sharing animation
www.youtube.com
November 24, 2025 at 8:30 AM
#ScienceReadForSunday: Genetic diversity of Trypanosoma cruzi in individuals with chronic Chagas disease in the Northern Minas Gerais and Vale do Jequitinhonha regions, Minas Gerais, Brazil
journals.plos.org/plosntds/art...
Genetic diversity of Trypanosoma cruzi in individuals with chronic Chagas disease in the Northern Minas Gerais and Vale do Jequitinhonha regions, Minas Gerais, Brazil
Author summary Even 115 years after its discovery, Chagas disease remains an endemic and neglected disease. Understanding the genetic diversity of Trypanosoma cruzi is essential to improve diagnosis…
journals.plos.org
November 23, 2025 at 10:15 AM
📢 📢ATTENTION RESEARCHERS 📢 📢
In this #AMRAwarenessWeek find out more about how you can reuse data in the #AMR repository to help combat one of the biggest threats to global health and development #WAAW
@gram-oxford.bsky.social @ndm.ox.ac.uk @tropicalmedicine.ox.ac.uk
www.iddo.org/amr/data-reu...
November 21, 2025 at 10:00 AM
Watch IDDO’s Dr Makoto Saito and Dr Yanina Borzykh to learn more about #AMR and how reusing data can support valuable research to combat #AntimicrobialResistance
#WAAW
@tropicalmedicine.ox.ac.uk @ndm.ox.ac.uk
Watch here ➡️ youtu.be/vjZmaWvUqIY
AMR Awareness Week
youtu.be
November 21, 2025 at 9:01 AM
Are you researching #InfectiousDiseases #EmergingInfections #malaria #AMR or #NTDs? The datasets we host harmonise tens of thousands of individual patient data, enabling researchers to answer new questions from existing data. Learn more www.iddo.org/data-sharing #BeatNTDs
November 20, 2025 at 10:30 AM
#AntimicrobialResistance is one of the biggest global threats to health and development! Use data in the #AMR repository, which includes data from 69 countries & 250k patients, to help further research & build knowledge.
@gram-oxford.bsky.social #WAAW
www.tropicalmedicine.ox.ac.uk/gram/news/gr...
November 20, 2025 at 9:15 AM
✨#WorldAMRWeek highlight✨
🦟#MARCSEAfrica assembles and analyses regional data on resistance to support fast, evidence-based policy to address the rising #AntimalarialResistance.
Explore recent updates presented at #TropMed25: tinyurl.com/4tjv8nuc
@globalhealthedctp3.bsky.social
November 20, 2025 at 8:30 AM
📢 Attention Researchers - need to make map showing data over time and location? But fed up having to waste time standardising basic data? IDDO Statistician Rhys Peploe has created a tool that could save you lots of time…
Introducing IDDO’s mapping tool worlddatr
#ToolsForResearchers
November 19, 2025 at 1:37 PM
#ScienceReadForSunday: Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
www.thelancet.com/journals/lan...
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
Both ensitrelvir and nirmatrelvir accelerate oropharyngeal SARS-CoV-2 viral clearance. Ensitrelvir is an effective alternative to currently available antivirals in treating COVID-19. Although…
www.thelancet.com
November 16, 2025 at 10:15 AM
Thanks for a great week at #TropMed25, if you missed our poster sessions or presentations or want to find out more about our work, please get in touch with us [email protected]
@tropicalmedicine.ox.ac.uk @astmh.bsky.social
www.linkedin.com/pulse/come-m...
November 14, 2025 at 2:15 PM